Home MAPK MNK

MNK

Isoform-selective Products

MNK Products

  • All (5)
  • MNK Inhibitors (4)
  • New MNK Products
Catalog No. Product Name Information Product Use Citations Product Validations
S8275 Tomivosertib (eFT-508) Tomivosertib (eFT-508) is a potent and selective MNK1/2 inhibitor with IC50s of 2.4 nM and 1 nM, respectively. It potentially results in decreased tumor cell proliferation and tumor growth. Tomivosertib (eFT-508) inhibits eIF4E phosphorylation and dramatically downregulates PD-L1 protein abundance.
Nat Commun, 2024, 15(1):9755
Nat Commun, 2024, 15(1):9755
J Clin Invest, 2024, 134(16)e168393
S7421 CGP 57380 CGP 57380 is a potent MNK1 inhibitor with IC50 of 2.2 μM, exhibiting no inhibitory activity on p38, JNK1, ERK1 and -2, PKC, or c-Src-like kinases. CGP 57380 upregulates β-catenin and potentiates radiation-induced apoptosis.
Sci Rep, 2025, 15(1):1973
Cell Commun Signal, 2023, 21(1):107
Fundam Clin Pharmacol, 2022, 10.1111/fcp.12759
S6888 SEL201 SEL-201 (SLV-2436, SEL201-88) is a highly potent and ATP-competitive inhibitor of MNK1 and MNK2 with IC50 of 10.8  nM and 5.4 nM, respectively.
Eur J Pharm Sci, 2022, 177:106278
F0582New Mnk1 Rabbit mAb
S6658 ETC-206 (AUM 001) ETC-206 (AUM 001, ETC-1907206) is an orally available highly selective small-molecule MNK 1/2 inhibitor with IC50s of 64 nM and 86 nM, respectively.
S8275 Tomivosertib (eFT-508) Tomivosertib (eFT-508) is a potent and selective MNK1/2 inhibitor with IC50s of 2.4 nM and 1 nM, respectively. It potentially results in decreased tumor cell proliferation and tumor growth. Tomivosertib (eFT-508) inhibits eIF4E phosphorylation and dramatically downregulates PD-L1 protein abundance.
Nat Commun, 2024, 15(1):9755
Nat Commun, 2024, 15(1):9755
J Clin Invest, 2024, 134(16)e168393
S7421 CGP 57380 CGP 57380 is a potent MNK1 inhibitor with IC50 of 2.2 μM, exhibiting no inhibitory activity on p38, JNK1, ERK1 and -2, PKC, or c-Src-like kinases. CGP 57380 upregulates β-catenin and potentiates radiation-induced apoptosis.
Sci Rep, 2025, 15(1):1973
Cell Commun Signal, 2023, 21(1):107
Fundam Clin Pharmacol, 2022, 10.1111/fcp.12759
S6888 SEL201 SEL-201 (SLV-2436, SEL201-88) is a highly potent and ATP-competitive inhibitor of MNK1 and MNK2 with IC50 of 10.8  nM and 5.4 nM, respectively.
Eur J Pharm Sci, 2022, 177:106278
S6658 ETC-206 (AUM 001) ETC-206 (AUM 001, ETC-1907206) is an orally available highly selective small-molecule MNK 1/2 inhibitor with IC50s of 64 nM and 86 nM, respectively.
F0582New Mnk1 Rabbit mAb

Choose Selective MNK Inhibitors

Tags: MNK activty | MNK inhibitor | MNK inhibitor review